Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer
Scholar Rock, a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases […]
Actinium Signs Cooperative Research and Development Agreement with National Cancer Institute
Actinium Pharmaceuticals, a leader in the development of targeted radiotherapies, have announced that it has […]
Roche Announces Positive Data from Global Phase III Programme for Crovalimab in PNH, a Rare Life-threatening Blood Condition
Roche has announced positive results from the global phase III COMMODORE 2 study, evaluating the […]
Ultima Genomics and Integrated DNA Technologies to Enable Application Portfolio on Ultima Sequencing Platforms
Ultima Genomics, a developer of a revolutionary new ultra-high throughput sequencing architecture, has announced a […]
Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program
Radiology Imaging Associates (RIA), a division of RadNet, has announced that it has started the […]
Halozyme Appoints Barbara Duncan to its Board of Directors
Halozyme Therapeutics today announced the appointment of Barbara Duncan to its Board of Directors. Ms. Duncan brings more […]
Dianosic Raises €4.7M to Bring Treatment for Chronic Rhinitis into Clinical Trial
Dianosic, a deeptech company specializing in the development of innovative solutions for the treatment of […]
Clexio and Genetika+ Announce Partnership Using Proprietary Antidepressant Screening Platform
As part of a shared commitment to bring better solutions for people suffering from depression, […]
Mihir Patel Joins Cambia Health Solutions as Chief Pharmacy Officer
Cambia Health Solutions has named Mihir Patel, Pharm.D., RPh, as its Chief Pharmacy Officer. In this […]
Sandoz Biologics License Application for Proposed Biosimilar Denosumab Accepted by US FDA
Sandoz, a global leader in off-patent (generic and biosimilar) medicines, today announced that the US […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more